Literature DB >> 20363371

Detective work in drug-induced liver injury: sometimes it is all about interviewing the right witness.

A Sidney Barritt1, Joseph Lee, Paul H Hayashi.   

Abstract

Diagnosing drug-induced liver injury (DILI) relies primarily on history taking. We report 4 cases in which DILI was missed or the drug was misidentified when physicians relied solely on patient history. We reviewed 27 cases referred with possible DILI from August 1, 2009, to February 1, 2010. Four patients seemed to be reliable historians, but their cases were greatly clarified by a call to their pharmacist. One subject, who forgot a new medication, underwent an unfruitful evaluation including surgery. Another patient had acetaminophen toxicity that was missed because she grossly underreported her pain medication use. The third and fourth patients forgot taking amoxicillin/clavulanate, so other agents mistakenly were implicated. Roussel Uclaf Causality Assessment Method scores were 8 (probable) or 9 (highly probable) for all 4 cases. Without pharmacy input, DILI was missed in 2 cases and the wrong agent was implicated twice. Reviewing pharmacy records can be crucial for patients and DILI research. We recommend calling the pharmacist directly for increased liver enzyme levels of unclear source or suspected DILI regardless of patient history. Copyright (c) 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20363371      PMCID: PMC3292181          DOI: 10.1016/j.cgh.2010.03.020

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  13 in total

Review 1.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

2.  Alfuzosin-induced hepatotoxicity.

Authors:  S Zabala; C Thomson; S Valdearcos; A Gascón; M A Pina
Journal:  J Clin Pharm Ther       Date:  2000-02       Impact factor: 2.512

3.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study.

Authors:  Anne M Larson; Julie Polson; Robert J Fontana; Timothy J Davern; Ezmina Lalani; Linda S Hynan; Joan S Reisch; Frank V Schiødt; George Ostapowicz; A Obaid Shakil; William M Lee
Journal:  Hepatology       Date:  2005-12       Impact factor: 17.425

5.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

6.  Measurement of serum acetaminophen-protein adducts in patients with acute liver failure.

Authors:  Timothy J Davern; Laura P James; Jack A Hinson; Julie Polson; Anne M Larson; Robert J Fontana; Ezmina Lalani; Santiago Munoz; A Obaid Shakil; William M Lee
Journal:  Gastroenterology       Date:  2006-03       Impact factor: 22.682

7.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

8.  Alfuzosin-induced acute liver injury.

Authors:  Seok Yeon Kim; Byung Ho Kim; Seok Ho Dong; Hyo Jong Kim; Young Woon Chang; Rin Chang; Yoon Wha Kim
Journal:  Korean J Hepatol       Date:  2007-09

9.  Alfuzosin-induced acute hepatitis in a patient with chronic liver disease.

Authors:  Omer Faruk Yolcu; Seyfettin Köklü; Aydin S Köksal; Osman Yüksel; Yavuz Beyazit; Omer Basar
Journal:  Ann Pharmacother       Date:  2004-07-27       Impact factor: 3.154

10.  Acute liver failure: Summary of a workshop.

Authors:  William M Lee; Robert H Squires; Scott L Nyberg; Edward Doo; Jay H Hoofnagle
Journal:  Hepatology       Date:  2008-04       Impact factor: 17.425

View more
  5 in total

1.  Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum.

Authors:  Jiabo Wang; Zhijie Ma; Ming Niu; Yun Zhu; Qingsheng Liang; Yanling Zhao; Jingyuan Song; Zhaofang Bai; Yaming Zhang; Ping Zhang; Na Li; Yakun Meng; Qi Li; Lushan Qin; Guangju Teng; Junling Cao; Baosen Li; Shilin Chen; Yonggang Li; Zhengsheng Zou; Honghao Zhou; Xiaohe Xiao
Journal:  Front Med       Date:  2015-10-12       Impact factor: 4.592

2.  Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report.

Authors:  Yaakov Hasin; Shimon Shteingart; Harel Dahari; Inna Gafanovich; Sharon Floru; Marius Braun; Amir Shlomai; Anthony Verstandig; Ilana Dery; Susan L Uprichard; Scott J Cotler; Yoav Lurie
Journal:  World J Hepatol       Date:  2016-07-18

Review 3.  Research Advances on Hepatotoxicity of Herbal Medicines in China.

Authors:  Changxiao Liu; Huirong Fan; Yazhuo Li; Xiaohe Xiao
Journal:  Biomed Res Int       Date:  2016-12-18       Impact factor: 3.411

4.  Cholestatic hepatitis with small duct injury associated with celecoxib.

Authors:  Suresh Kumar Nayudu; Shanti Badipatla; Masooma Niazi; Bhavna Balar
Journal:  Case Rep Med       Date:  2013-06-05

5.  Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury.

Authors:  Jia-Bo Wang; Yun Zhu; Zhao-Fang Bai; Fu-Sheng Wang; Xiu-Hui Li; Xiao-He Xiao
Journal:  Chin J Integr Med       Date:  2018-03-15       Impact factor: 2.626

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.